Related Experiment Video

Updated: Feb 19, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.1K

[COSYREL - an efficient fixed combination for treatment of hypertension, stable ISHD and heart failure]

Jiří Widimský

    Vnitrni Lekarstvi
    |November 12, 2017
    PubMed

    Insights

    Fixed drug combinations improve patient adherence and disease control in cardiovascular conditions. Cosyrel, combining bisoprolol (a beta-blocker) and perindopril (an ACE inhibitor), offers improved management for hypertension, coronary artery disease, and heart failure.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Fixed-dose drug combinations enhance patient adherence and therapeutic outcomes in managing cardiovascular diseases.
    • Hypertension and coronary artery disease (CAD) frequently utilize combination therapies.
    • Cosyrel represents the first fixed combination of bisoprolol (beta-blocker) and perindopril arginin (ACE inhibitor) available in the Czech market.

    Purpose of the Study:

    • To provide a concise evaluation of the clinical characteristics of the fixed-dose combination Cosyrel.
    • To highlight the therapeutic applications of bisoprolol and perindopril arginin in cardiovascular disease management.

    Main Methods:

    • Review of clinical data and characteristics of the fixed combination of bisoprolol and perindopril arginin.
    • Analysis of available dosage strengths and their indications.

    Main Results:

    • Cosyrel is available in multiple concentrations (e.g., 10 mg/10 mg, 10 mg/5 mg, 5 mg/10 mg, 5 mg/5 mg), with the first dose indicating bisoprolol and the second perindopril.
    • Indications include arterial hypertension, stable coronary artery disease (post-myocardial infarction or revascularization), and chronic heart failure with systolic dysfunction (specific dosages).

    Conclusions:

    • Bisoprolol and perindopril arginin possess established evidence supporting their positive impact on cardiovascular risk and prognosis.
    • The fixed combination Cosyrel offers a convenient therapeutic option for patients with hypertension, CAD, and heart failure, potentially improving long-term management.

    More Related Videos

    Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

    Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

    Published on: December 11, 2017

    11.1K

    Related Concept Videos

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    1.2K
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    377
    Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

    Hypertension IV: Drug Therapy and Lifestyle Modifications

    Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
    742
    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
    529
    Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

    Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

    Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
    TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
    570
    Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

    Cardiovascular Drugs: Classification based on Therapeutic Indications

    Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
    4.3K